145 related articles for article (PubMed ID: 10762693)
1. Concurrent modulation of anxiety and memory.
Wall PM; Messier C
Behav Brain Res; 2000 May; 109(2):229-41. PubMed ID: 10762693
[TBL] [Abstract][Full Text] [Related]
2. U-69,593 microinjection in the infralimbic cortex reduces anxiety and enhances spontaneous alternation memory in mice.
Wall PM; Messier C
Brain Res; 2000 Feb; 856(1-2):259-80. PubMed ID: 10677636
[TBL] [Abstract][Full Text] [Related]
3. Infralimbic kappa opioid and muscarinic M1 receptor interactions in the concurrent modulation of anxiety and memory.
Wall PM; Messier C
Psychopharmacology (Berl); 2002 Mar; 160(3):233-44. PubMed ID: 11889492
[TBL] [Abstract][Full Text] [Related]
4. Infralimbic muscarinic M1 receptors modulate anxiety-like behaviour and spontaneous working memory in mice.
Wall PM; Flinn J; Messier C
Psychopharmacology (Berl); 2001 Apr; 155(1):58-68. PubMed ID: 11374337
[TBL] [Abstract][Full Text] [Related]
5. Infralimbic D1 receptor agonist effects on spontaneous novelty exploration and anxiety-like defensive responding in CD-1 mice.
Wall PM; Blanchard RJ; Markham C; Yang M; Blanchard DC
Behav Brain Res; 2004 Jun; 152(1):67-79. PubMed ID: 15135970
[TBL] [Abstract][Full Text] [Related]
6. Infralimbic D2 receptor influences on anxiety-like behavior and active memory/attention in CD-1 mice.
Wall PM; Blanchard RJ; Yang M; Blanchard DC
Prog Neuropsychopharmacol Biol Psychiatry; 2003 May; 27(3):395-410. PubMed ID: 12691774
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of infralimbic vs. ventromedial orbital PFC lidocaine infusions in CD-1 mice on defensive responding in the mouse defense test battery and rat exposure test.
Wall PM; Blanchard RJ; Yang M; Blanchard DC
Brain Res; 2004 Sep; 1020(1-2):73-85. PubMed ID: 15312789
[TBL] [Abstract][Full Text] [Related]
8. κ Opioid receptor activation in different brain regions differentially modulates anxiety-related behaviors in mice.
Wang YJ; Hang A; Lu YC; Long Y; Zan GY; Li XP; Wang Q; Zhao ZX; He L; Chi ZQ; Liu JG
Neuropharmacology; 2016 Nov; 110(Pt A):92-101. PubMed ID: 27106167
[TBL] [Abstract][Full Text] [Related]
9. Two short-acting kappa opioid receptor antagonists (zyklophin and LY2444296) exhibited different behavioral effects from the long-acting antagonist norbinaltorphimine in mouse anxiety tests.
Huang P; Yakovleva T; Aldrich JV; Tunis J; Parry C; Liu-Chen LY
Neurosci Lett; 2016 Feb; 615():15-20. PubMed ID: 26780565
[TBL] [Abstract][Full Text] [Related]
10. Effects of a post-shock injection of the kappa opioid receptor antagonist norbinaltorphimine (norBNI) on fear and anxiety in rats.
Rogala B; Li Y; Li S; Chen X; Kirouac GJ
PLoS One; 2012; 7(11):e49669. PubMed ID: 23166745
[TBL] [Abstract][Full Text] [Related]
11. Transient activation of the CA3 Kappa opioid system in the dorsal hippocampus modulates complex memory processing in mice.
Daumas S; Betourne A; Halley H; Wolfer DP; Lipp HP; Lassalle JM; Francés B
Neurobiol Learn Mem; 2007 Jul; 88(1):94-103. PubMed ID: 17374494
[TBL] [Abstract][Full Text] [Related]
12. CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour.
Rubino T; Guidali C; Vigano D; Realini N; Valenti M; Massi P; Parolaro D
Neuropharmacology; 2008 Jan; 54(1):151-60. PubMed ID: 17692344
[TBL] [Abstract][Full Text] [Related]
13. Involvement of the opioid system in the effects induced by nicotine on anxiety-like behaviour in mice.
Balerio GN; Aso E; Maldonado R
Psychopharmacology (Berl); 2005 Sep; 181(2):260-9. PubMed ID: 15778877
[TBL] [Abstract][Full Text] [Related]
14. Kappa opioid agonists produce anxiolytic-like behavior on the elevated plus-maze.
Privette TH; Terrian DM
Psychopharmacology (Berl); 1995 Apr; 118(4):444-50. PubMed ID: 7568631
[TBL] [Abstract][Full Text] [Related]
15. Effects of intra-infralimbic prefrontal cortex injections of cannabidiol in the modulation of emotional behaviors in rats: contribution of 5HT₁A receptors and stressful experiences.
Marinho AL; Vila-Verde C; Fogaça MV; Guimarães FS
Behav Brain Res; 2015 Jun; 286():49-56. PubMed ID: 25701682
[TBL] [Abstract][Full Text] [Related]
16. The kappa-opioid receptor is involved in the stimulating effect of nicotine on adrenocortical activity but not in nicotine induced anxiety.
Marco EM; Llorente R; Pérez-Alvarez L; Moreno E; Guaza C; Viveros MP
Behav Brain Res; 2005 Sep; 163(2):212-8. PubMed ID: 15979169
[TBL] [Abstract][Full Text] [Related]
17. Modulation of behaviour on trials 1 and 2 in the elevated plus-maze test of anxiety after systemic and hippocampal administration of nicotine.
Ouagazzal AM; Kenny PJ; File SE
Psychopharmacology (Berl); 1999 May; 144(1):54-60. PubMed ID: 10379624
[TBL] [Abstract][Full Text] [Related]
18. Modulation of anxiety-related behaviors by mu- and kappa-opioid receptor agonists depends on the social status of mice.
Kudryavtseva NN; Gerrits MA; Avgustinovich DF; Tenditnik MV; Van Ree JM
Peptides; 2004 Aug; 25(8):1355-63. PubMed ID: 15350704
[TBL] [Abstract][Full Text] [Related]
19. Effects of selective excitotoxic prefrontal lesions on acquisition of nonmatching- and matching-to-place in the T-maze in the rat: differential involvement of the prelimbic-infralimbic and anterior cingulate cortices in providing behavioural flexibility.
Dias R; Aggleton JP
Eur J Neurosci; 2000 Dec; 12(12):4457-66. PubMed ID: 11122356
[TBL] [Abstract][Full Text] [Related]
20. Anxiolytic-like effects induced by medial prefrontal cortex inhibition in rats submitted to the Vogel conflict test.
Resstel LB; Souza RF; Guimarães FS
Physiol Behav; 2008 Jan; 93(1-2):200-5. PubMed ID: 17884112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
